Intratumoral lymphatic vessels and VEGF-C expression are predictive factors of lymph node relapse in T1-T4 N0 laryngopharyngeal squamous cell carcinoma

Ann Surg Oncol. 2007 Jan;14(1):248-57. doi: 10.1245/s10434-006-9201-y. Epub 2006 Oct 25.

Abstract

Background: The presence of intratumoral lymphatic vessels (ILVs) and the expression of vascular endothelial growth factor-C (VEGF-C) in tumour cells have been studied as markers of lymphangiogenesis in order to evaluate their role in metastatic dissemination in laryngopharyngeal squamous cell carcinoma.

Methods: A retrospective study was performed in 76 patients of N0 laryngopharyngeal carcinoma. with variable tumour size (T1-T4), histological grade, and location (supraglottic, glottic and hypopharyngeal). The presence of ILVs, as revealed by the expression of PA2.26 antigen and VEGF-C expression, were determined by immunohistochemistry (IHC). Low-grade and high-grade lymphangiogenesis were defined by qualitative and quantitative criteria.

Results: Multivariate analysis revealed low-grade ILV and VEGF-C expression to be associated respectively with 30.3- and 16.2-fold higher probabilities of cervical lymph node relapse (P = 0.005 and P = 0.032) and with 16.2- and 8.44-fold shorter disease-free survival (P = 0.009 and P = 0.045).

Conclusions: Low-grade ILV and VEGF-C expression are independent predictive factors of cervical lymph node relapse and shortening of time to relapse in N0 laryngopharyngeal carcinoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine-5'-(N-ethylcarboxamide)
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell / chemistry
  • Carcinoma, Squamous Cell / pathology*
  • Carcinoma, Squamous Cell / secondary
  • Female
  • Humans
  • Laryngeal Neoplasms / chemistry
  • Laryngeal Neoplasms / pathology*
  • Lymphangiogenesis*
  • Lymphatic Metastasis
  • Lymphatic Vessels / pathology
  • Male
  • Middle Aged
  • Pharyngeal Neoplasms / chemistry
  • Pharyngeal Neoplasms / pathology*
  • Vascular Endothelial Growth Factor C / analysis*

Substances

  • Vascular Endothelial Growth Factor C
  • Adenosine-5'-(N-ethylcarboxamide)